117. In Wyeth v. Levine, where Levine sued the drug developer Wyeth for failure to warn after she lost her forearm
and hand after being given a drug by IV–push, a method known to have risks, the U.S. Supreme Court:
a. dismissed the state court‘s judgment for Levine because it was impossible for Wyeth to comply with both
federal and state labeling regulations
b. dismissed the state court‘s judgment for Levine because it was not impossible for Wyeth to comply with both
federal and state labeling regulations
c. reversed the state court’s decision for Levine and ordered her to pay Wyeth’s attorney fees
d. awarded Levine additional damages
e. none of the other choices are correct
118. The “learned intermediary” doctrine:
a. shields a physician from liability because of a drug company’s mistake in dosage instructions
b. is invoked by regulatory agencies in their arguments in court arguments in support of new regulations
c. shields a drug manufacturer from liability when the doctor is liable for misuse of the drug
d. holds that the FDA has gone too far in preventing new, effective drugs from reaching the market in less time
e. holds federal regulatory agencies supreme in all matters regarding control of product safety
119. The “learned intermediary” doctrine:
a. shields a physician from liability because of a drug company’s mistake in dosage instructions
b. is invoked by regulatory agencies in their arguments in court arguments in support of new regulations
c. holds federal regulatory agencies supreme in all matters regarding control of product safety
d. holds that the FDA has gone too far in preventing new, effective drugs from reaching the market in less time
e. none of the other choices